Latest News for IBO
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Impact Biomedical Inc. (NYSE American: IBO) resulting from allegations that Impact Biomedical may have issued materially misleading business information to the investing public. So what: If you purchased Impact Biomedical securities you may be…
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Impact Biomedical Inc. (NYSE American: IBO) resulting from allegations that Impact Biomedical may have issued materially misleading business information to the investing public. So what: If you purchased Impact Biomedical securities you may be…
HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026, includes an audit opinion from Grassi & Co., CPAs, P.C. that contains a "going concern" qualification. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IBO.
U.S. House Trading
No House trades found for IBO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.